http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2268745-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 |
| filingDate | 2003-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e86cf028c0fb2b15e3cc1060b7a194d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee6f1ffafe10c807fed8ee7fdc28e075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_344c17eb311d7ef4ccf061883355f11e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_009708b40d7b53d577d87d6b79f8fec9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8cb30db8b4dee4ffbba4b518f21a55d |
| publicationDate | 2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2268745-C2 |
| titleOfInvention | Method for preventing and(or) treating anemia in children (variants) |
| abstract | FIELD: medicine, pediatrics, hematology. n SUBSTANCE: the present innovation could be applied in treating surgical and oncological diseases in children during treating and preventing anemia of different etiology. One should introduce ceruloplasmin at daily single dosage ranged 50-200 mg depending upon child's age against 100-200 ml 0.9%-sodiumchloride solution intravenously by drops at the rate of 40-50 drops/min. Moreover, for preventing and/or treating posthemorrhagic anemia in case of surgical operations one should introduce ceruloplasmin during 2 d before surgical operation, intraoperationally, and for 2-10 d after operation. For preventing and/or treating anemia in case of purulent-septic diseases ceruloplasmin should be introduced during chemotherapeutic days during the whole period of the course conducted, for preventing and treating radiation anemia at the background of radiation therapy ceruloplasmin should be injected once weekly during the whole period of radiotherapy course, for preventing and treating toxic and radiation anemia at the background of chemoradiation therapy ceruloplasmin should be introduced once weekly on the day of chemotherapy during the whole course of chemoradiation treatment. The innovation enables to avoid inflows of erythrocytic mass and donor's blood along with shortened number of procedures on introduction of ceruloplasmin and 4-times decrease in the risk for the development of severe anemia in children due to matching peculiar mode for ceruloplasmin introduction. n EFFECT: higher efficiency of therapy and prophylaxis. n 4 cl, 5 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2662148-C1 |
| priorityDate | 2003-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.